📰 Evaluate Pharma News
Page 3 - Evaluate Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evaluate Pharma. Real-time updates on events, politics, business and more.
September 20, 2023
This company is on the brink of a major breakthrough.
September 17, 2023
The stock has delivered market-beating returns in the past. It can do it again.
September 16, 2023
The stock has delivered market-beating returns in the past. It can do it again.
September 15, 2023
Revenue at all three companies improved last quarter, and their share prices have followed suit.
September 5, 2023
Big news could come in December and in March.
September 5, 2023
Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
August 16, 2023
Shares of the giant drugmaker aren't far off their 52-week high.
August 15, 2023
Mike Gallup, CEO of Norstella, Evaluate’s parent company said: “Key assumptions that have underpinned the pharmaceutical sector for so long – for example, the US market’s supreme profitability and reliance on big M&A to fuel growth – are being tested. “The far-reaching Inflation Reduction Act (IRA), combined with ...
August 9, 2023
Neither has performed well over the past year, but investors would do well to focus on the longer term.
August 1, 2023
Pharmaceutical company Merck & Company (NYSE: MRK) reports second quarter financial results before market open Tuesday.